Colistin: understanding and applying recent pharmacokinetic advances (Q38246001)

31 August 2017

title

Colistin: understanding and applying recent pharmacokinetic advances (English)

1 reference

31 August 2017

1 reference

2

Keith S Kaye

1 reference

31 August 2017

Jessica K Ortwine

1

1 reference

31 August 2017

Jian Li

series ordinal

3

1 reference

31 August 2017

Jason M Pogue

series ordinal

4

1 reference

31 August 2017

language of work or name

English

0 references

publication date

3 September 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

35

1 reference

31 August 2017

issue

1

1 reference

31 August 2017

page(s)

11-16

1 reference

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

31 August 2017

cites work

1 reference

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

21 January 2018

1 reference

Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

21 January 2018

1 reference

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

21 January 2018

1 reference

Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography.

21 January 2018

1 reference

Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography

21 January 2018

1 reference

Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill

21 January 2018

1 reference

Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens.

21 January 2018

1 reference

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study

21 January 2018

1 reference

Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models

21 January 2018

1 reference

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

21 January 2018

1 reference

Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens

21 January 2018

1 reference

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

21 January 2018

1 reference

Colistin dosing and nephrotoxicity in a large community teaching hospital

21 January 2018

1 reference

Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system

21 January 2018

1 reference

High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

21 January 2018

1 reference

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

21 January 2018

1 reference

Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?

21 January 2018

1 reference

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PHAR.1484

1 reference

31 August 2017

1 reference